Neurocritical Care study links GLP-1 agonist use to survival after surgical TBI

The wire

1. 01Researchers report an association between GLP-1 receptor agonist use and survival among surgically treated traumatic brain injury patients, published in Neurocritical Care on October 5.
2. 02Clinicians managing patients already on semaglutide or tirzepatide may face questions about perioperative continuation in neurotrauma settings.
3. 03An observational association cannot establish causation, and details on cohort size, drug mix and confounding adjustment are needed before any practice change.

From the source

Association Between GLP-1 RECEPTOR Agonist use and Survival in Surgically Treated Patients with Traumatic Brain Injury

Neurocritical care · 2026 Oct 5 · Khor WT, Chi KY, Chang Y et al.